Skip to content
Search

Latest Stories

Peak Pharmacy to use state-of-the-art robots to process over 40 prescriptions every minute

Peak Pharmacy says it is building an ultra-modern headquarters in Derbyshire, which will process millions of prescriptions per year for patients.

A £20m initiative called Project Horizon is expected to begin a new chapter for the Chesterfield-based pharmacy chain. Construction work has started on a new service centre at Markham Vale to handle prescriptions and dispatch medicines for its 150 community pharmacies across England.


Prescriptions will be assembled for individual patients before they are delivered either to local pharmacies for collection the next day or sent directly to patients.

The facility will use state-of-the-art robots and automated systems to support staff handling over 400,000 medicines and other prescribed items every month – that’s 20,000 a day, more than 40 every minute.

Peak Pharmacy’s move is in response to caps in government funding, which mean that pharmacy businesses are having to be more efficient in how they handle prescriptions.

Centralising the process will also free up local pharmacists and Peak Pharmacy staff to provide other services for patients, such as vaccinations, blood pressure checks and healthy living advice.

Peak Pharmacy Photo 1 From left to right - Peter Cattee (Founder and Director), DarrylDethick (Head of Business Transformation), Joe Cattee (Managing Director)


Managing director Joe Cattee, whose parents Peter and Jane founded Peak Pharmacy in 1981, said: “These are ambitious plans for our company, staff and customers – in the face of a rapidly changing pharmacy landscape.

“This will be transformational for us. We’re investing now to future-proof our business, so that we can continue to provide great local customer service which means so much to us.”

The new hub -- due to open in April next year -- will house up to 100 staff, with the potential to grow into a 24-hour operation in future.

Peak Pharmacy is planning to be in a position to offer a centralised dispensing service to other independent pharmacies which don’t have the resources to develop their own centralised service, should the legislation allowing this change in the near future.

Cattee added: “We’re inviting other pharmacies to contact us now, so we can show them how our hub can benefit them too.”

The company is investing more than £20m on Project Horizon, a significant proportion of which will be spent on automation technology. Around 40 per cent of all prescriptions can be processed in this way.

The project will replace five smaller existing Peak Pharmacy sites in Derbyshire. The new hub, on the site of the former Coalite coking plant in Bolsover, will cover 113,000 square feet; have a continued focus on sustainability, with energy efficiency measures, electric charge points for colleague and business vehicles, major tree-planting and a bat box; and provide an excellent working environment for staff including a canteen and leisure facilities.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less